[HTML][HTML] Liposomal amphotericin B for treatment of leishmaniasis: from the identification of critical physicochemical attributes to the design of effective topical and oral …

F Frézard, MMG Aguiar, LAM Ferreira, GS Ramos… - Pharmaceutics, 2022 - mdpi.com
The liposomal amphotericin B (AmB) formulation, AmBisome®, still represents the best
therapeutic option for cutaneous and visceral leishmaniasis. However, its clinical efficacy …

[HTML][HTML] Flavonoid Components, Distribution, and Biological Activities in Taxus: A review

Q Wei, QZ Li, RL Wang - Molecules, 2023 - mdpi.com
Taxus, also known as “gold in plants” because of the famous agents with emphases on
Taxol and Docetaxel, is a genus of the family Taxaceae, distributed almost around the world …

[HTML][HTML] Lactoferrin as a component of pharmaceutical preparations: An experimental focus

F Guzmán-Mejía, M Godínez-Victoria… - Pharmaceuticals, 2023 - mdpi.com
Lactoferrin is an 80 kDa monomeric glycoprotein that exhibits multitask activities. Lactoferrin
properties are of interest in the pharmaceutical field for the design of products with …

[HTML][HTML] Review of novel oral amphotericin B formulations for the treatment of parasitic infections

E Wasan, T Mandava, P Crespo-Moran, A Nagy… - Pharmaceutics, 2022 - mdpi.com
Amphotericin B (AmpB) is a polyene macrolide antibiotic used in the treatment of blood-
borne parasitic and fungal infections. However, its use, particularly in the developing world …

Anti-Leishmania compounds can be screened using Leishmania spp. expressing red fluorescence (tdTomato)

MGFML Cruz, AMM Santi… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
The main challenges associated with leishmaniasis chemotherapy are drug toxicity, the
possible emergence of resistant parasites, and a limited choice of therapeutic agents …

The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice

DP Lage, VT Martins, DL Vale, CS Freitas, BL Pimenta… - Acta Tropica, 2023 - Elsevier
Abstract Treatment of visceral leishmaniasis (VL) is compromised by drug toxicity, high cost
and/or the emergence of resistant strains. Though canine vaccines are available, there are …

[HTML][HTML] In vitro evaluation of aerosol therapy with pentamidine-loaded liposomes coated with chondroitin sulfate or heparin for the treatment of Leishmaniasis

L Román-Álamo, M Allaw, Y Avalos-Padilla, ML Manca… - Pharmaceutics, 2023 - mdpi.com
The second-line antileishmanial compound pentamidine is administered intramuscularly or,
preferably, by intravenous infusion, with its use limited by severe adverse effects, including …

Rational repurposing, synthesis, in vitro and in silico studies of chromone-peptidyl hybrids as potential agents against Leishmania donovani

AHE Hassan, WA Bayoumi, SM El-Sayed… - Journal of enzyme …, 2023 - Taylor & Francis
A chromone-peptidyl hybrids series was synthesised and rationally repurposed towards
identification of potential antileishmanial hits against visceral leishmaniasis. Three hybrids …

Clotrimazole causes membrane depolarization and induces sub G0 cell cycle arrest in Leishmania donovani

A Paul, PK Roy, NK Babu, S Singh - Acta Tropica, 2024 - Elsevier
Clotrimazole is an FDA approved drug and is widely used as an antifungal agent. An
extensive body of research is available about its mechanism of action on various cell types …

[HTML][HTML] Polyamine Metabolism for Drug Intervention in Trypanosomatids

Y Pérez-Pertejo, C García-Estrada… - Pathogens, 2024 - mdpi.com
Neglected tropical diseases transmitted by trypanosomatids include three major human
scourges that globally affect the world's poorest people: African trypanosomiasis or sleeping …